Found: 8
Select item for more details and to access through your institution.
First-In-Human Effects of PPT1 Inhibition Using the Oral Treatment with GNS561/Ezurpimtrostat in Patients with Primary and Secondary Liver Cancers.
- Published in:
- Liver Cancer (2235-1795), 2022, v. 11, n. 3, p. 268, doi. 10.1159/000522418
- By:
- Publication type:
- Article
Targeting p53-dependent stem cell loss for intestinal chemoprotection.
- Published in:
- Science Translational Medicine, 2018, v. 10, n. 427, p. 1, doi. 10.1126/scitranslmed.aam7610
- By:
- Publication type:
- Article
GNS561 acts as a potent anti-fibrotic and pro-fibrolytic agent in liver fibrosis through TGF-β1 inhibition.
- Published in:
- Therapeutic Advances in Chronic Disease, 2020, v. 11, p. 1, doi. 10.1177/2040622320942042
- By:
- Publication type:
- Article
GNS561 acts as a potent anti-fibrotic and pro-fibrolytic agent in liver fibrosis through TGF-β1 inhibition.
- Published in:
- Therapeutic Advances in Chronic Disease, 2020, v. 11, p. 1, doi. 10.1177/2040622320942042
- By:
- Publication type:
- Article
Phase I study of veliparib in combination with gemcitabine.
- Published in:
- 2017
- By:
- Publication type:
- journal article
GNS561 Exhibits Potent Antiviral Activity against SARS-CoV-2 through Autophagy Inhibition.
- Published in:
- Viruses (1999-4915), 2022, v. 14, n. 1, p. 132, doi. 10.3390/v14010132
- By:
- Publication type:
- Article
GNS561 acts as a potent anti-fibrotic and pro-fibrolytic agent in liver fibrosis through TGF-β1 inhibition.
- Published in:
- Therapeutic Advances in Musculoskeletal Disease, 2020, v. 12, p. 1, doi. 10.1177/2040622320942042
- By:
- Publication type:
- Article
Ezurpimtrostat, A Palmitoyl-Protein Thioesterase-1 Inhibitor, Combined with PD-1 Inhibition Provides CD8<sup>+</sup> Lymphocyte Repopulation in Hepatocellular Carcinoma.
- Published in:
- Targeted Oncology, 2024, v. 19, n. 1, p. 95, doi. 10.1007/s11523-023-01019-8
- By:
- Publication type:
- Article